J. Cui

Psoralidin, a prenylated coumestan, as a novel anti‐osteoporosis candidate to enhance bone formation of osteoblasts and decrease bone resorption of osteoclasts

Li Chen, Yanping Wang, Yingying Li, 2017, European journal of pharmacology.

The higher osteoprotective activity of psoralidin in vivo than coumestrol is attributed by its presence of an isopentenyl group and through activated PI3K/Akt axis.

C. Xian, Yingying Li, Yuankun Zhai, 2018, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie.

Inhibition of telomerase activity by dominant-negative hTERT retards the growth of breast cancer cells

W. Xiong, J. Cui, Huijuan Liu, 2016, Breast Cancer.

Local expression and role of BMP-2/4 in injured spinal cord.

H. Liu, P. Zhao, B. Lin, 2015, Genetics and molecular research : GMR.